We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+0.42%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.12B
AUM Growth
+$762M
(+14%)
Cap. Flow
+$908M
Cap. Flow
% of AUM
14.82%
Top 10 Holdings %
Top 10 Hldgs %
15.76%
Holding
794
New
208
Increased
110
Reduced
107
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$85M |
| 2 |
Abbott
ABT
|
+$72M |
| 3 |
NVIDIA
NVDA
|
+$60.9M |
| 4 |
Teradyne
TER
|
+$52.2M |
| 5 |
Legend Biotech
LEGN
|
+$50.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$98.7M |
| 2 |
Texas Instruments
TXN
|
+$95.4M |
| 3 |
Global Payments
GPN
|
+$54.3M |
| 4 |
Johnson & Johnson
JNJ
|
+$49.4M |
| 5 |
KLA
KLAC
|
+$49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.26% |
| 2 | Technology | 25.67% |
| 3 | Communication Services | 8.98% |
| 4 | Financials | 5.47% |
| 5 | Consumer Staples | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Twilio
TWLO
$29.8B
| $10.8M | 0.18% |
+33,857
| New | +$12.3M |
|
152
Cullinan Oncology
CGEM
$999M
| $10.7M | 0.18% |
475,058
-86,148
| -15% | -$2.3M |
|
153
Aclaris Therapeutics
ACRS
$772M
| $10.7M | 0.17% |
+594,768
| New | +$9.53M |
|
|
FOE
154
DELISTED
Ferro Corporation
FOE
| $10.6M | 0.17% |
+520,331
| New | +$10.8M |
|
|
SEEL
155
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $10.6M | 0.17% |
1,140
+347
| +44% | +$2.98M |
|
156
Arvinas
ARVN
$520M
| $10.5M | 0.17% |
128,250
| – | – |
|
|
KRON
157
DELISTED
Kronos Bio
KRON
| $10.5M | 0.17% |
500,628
| – | – |
|
|
SIEN
158
DELISTED
Sientra, Inc.
SIEN
| $10.5M | 0.17% |
182,830
+153,230
| +518% | +$10.5M |
|
|
HMCO
159
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
| $10.4M | 0.17% |
1,055,321
| – | – |
|
160
Outset Medical
OM
$92.5M
| $10.3M | 0.17% |
13,879
+1,650
| +13% | +$1.12M |
|
161
Fidelity National Information Services
FIS
$23.1B
| $10.2M | 0.17% |
84,061
-157,552
| -65% | -$21.1M |
|
162
Estee Lauder
EL
$30.6B
| $10.2M | 0.17% |
33,933
+13,173
| +63% | +$4.3M |
|
|
MDLA
163
DELISTED
Medallia, Inc.
MDLA
| $9.99M | 0.16% |
+294,914
| New | +$9.85M |
|
164
Stryker
SYK
$131B
| $9.97M | 0.16% |
+37,826
| New | +$10.1M |
|
165
BlackLine
BL
$1.92B
| $9.82M | 0.16% |
+83,143
| New | +$9.55M |
|
166
Acadia Pharmaceuticals
ACAD
$4.39B
| $9.78M | 0.16% |
588,859
-74,195
| -11% | -$1.43M |
|
|
NUAN
167
DELISTED
Nuance Communications, Inc.
NUAN
| $9.62M | 0.16% |
+174,845
| New | +$9.61M |
|
168
Celsius Holdings
CELH
$7.22B
| $9.62M | 0.16% |
320,232
+180,117
| +129% | +$4.63M |
|
169
Acadia Healthcare
ACHC
$2.85B
| $9.56M | 0.16% |
149,968
-137,895
| -48% | -$8.7M |
|
|
VERV
170
DELISTED
Verve Therapeutics
VERV
| $9.52M | 0.16% |
202,500
-4,421
| -2% | -$260K |
|
171
Sana Biotechnology
SANA
$885M
| $9.46M | 0.15% |
419,867
+9,019
| +2% | +$189K |
|
172
eBay
EBAY
$47.6B
| $9.42M | 0.15% |
+135,270
| New | +$9.69M |
|
173
Chemed
CHE
$7.18B
| $9.28M | 0.15% |
19,949
-12,260
| -38% | -$5.78M |
|
|
WBT
174
DELISTED
Welbilt, Inc.
WBT
| $9.26M | 0.15% |
+398,323
| New | +$9.36M |
|
175
Fate Therapeutics
FATE
$291M
| $9.07M | 0.15% |
152,957
+21,851
| +17% | +$1.71M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Woodline Partners held 794 positions worth $6.12B, up 14% from $5.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners deployed $908M of net new capital in Q3 2021, opening 208 new positions and adding to 110 existing holdings. Its largest new stake was Qualcomm: 599,018 shares worth $77.3M.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 47% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Amphenol, an estimated $98.7M trimmed.
- Woodline Partners's largest Q3 2021 buy was Qualcomm: 599,018 shares worth $77.3M.
- Woodline Partners added most to Teradyne in Q3 2021, an estimated $52.2M increase.
- Woodline Partners's biggest Q3 2021 reduction was Amphenol, cutting an estimated $98.7M.
- Woodline Partners fully exited Boston Scientific in Q3 2021, selling an estimated $44.9M.
- Woodline Partners's ten largest holdings make up 16% of its $6.12B portfolio in Q3 2021.
- Woodline Partners opened 208 new positions and closed 121 in Q3 2021.
- Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.12B.
Based on Woodline Partners's 13F filing for Q3 2021, filed 15 Nov 2021.